Scarica l'app Stockscreener
34.94
2.02%
-0.72
Dopo l'orario di chiusura:
34.94
Verona Pharma Plc Adr Borsa (VRNA) Ultime notizie
Verona Pharma director Christina Ackermann acquires $198,385 in shares - Investing.com
Verona Pharma director David Ebsworth buys $188,880 in shares - Investing.com
Verona Pharma CFO Mark Hahn sells shares worth $568,386 - Investing.com
Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre By Investing.com - Investing.com Nigeria
Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre - Investing.com India
Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday - Investing.com Nigeria
Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday By Investing.com - Investing.com South Africa
Verona Pharma ADR earnings matched, revenue topped estimates By Investing.com - Investing.com UK
Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.
Verona Pharma CFO Mark Hahn sells shares worth $632,760 - Investing.com India
Verona Pharma CEO David Zaccardelli sells shares worth $633,895 - Investing.com India
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma - Barchart
5 Biotech Stocks Likely To Outperform As Industry Prospects Look Bright - Barchart
Verona Pharma CEO David Zaccardelli sells $2.25 million in shares - Investing.com India
Verona Pharma CEO David Zaccardelli sells $2.25 million in shares By Investing.com - Investing.com South Africa
Verona Pharma CFO Mark Hahn sells shares worth $2.3 million By Investing.com - Investing.com South Africa
Verona Pharma CFO Mark Hahn sells shares worth $2.3 million - Investing.com India
Market Insights: Verona Pharma Plc ADR (VRNA)’s Notable Drop of -0.55, Closing at 34.07 - The Dwinnex
Verona Pharma Plc ADR [VRNA] Insider Activity: An Update for Investors - Knox Daily
Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily
Verona Pharma Plc ADR (VRNA) stock: A year of ups and downs - US Post News
VRNA Shares Experience Decline in Value - Knox Daily
Financial Metrics Exploration: Understanding Verona Pharma Plc ADR (VRNA) Through Ratios - The Dwinnex
A stock that deserves closer examination: Verona Pharma Plc ADR (VRNA) - US Post News
Wells Fargo gives an Overweight recommendation for Verona Pharma Plc ADR (VRNA) - Knox Daily
Verona Pharma Plc ADR’s (NASDAQ: VRNA) Stock Forecast: Increase To $38 In A Year - Stocks Register
Prepare Yourself for Liftoff: Verona Pharma Plc ADR (VRNA) - SETE News
Verona Pharma Plc ADR [VRNA] stock for 2,254,320 USD was sold by ZACCARDELLI DAVID - Knox Daily
Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains? - Yahoo Finance
Cactus Inc [WHD] Records 50-Day SMA of $59.34 - Knox Daily
Verona Pharma stock soars to all-time high of $30.76 By Investing.com - Investing.com South Africa
Piper Sandler maintains Overweight rating on Verona Pharma shares By Investing.com - Investing.com South Africa
Sea Limited Sponsored ADR (SE) Stock Moves -0.17%: What You Should Know - Yahoo Finance
Verona Pharma stock soars to all-time high of $30.76 - Investing.com
VRNA’s Stock Market Adventure: 58.43% YTD Growth Amidst Volatility - The InvestChronicle
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Moves 6.2% Higher: Will This Strength Last? - Yahoo Finance
MINISO Group Holding Limited Unsponsored ADR (MNSO) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Verona Pharma Plc ADR (VRNA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Investing in Verona Pharma Plc ADR (VRNA) might be a great opportunity, but the stock is a bit overvalued - US Post News
Upcoming Stock Splits This Week (September 30 to October 4) – Stay Invested - Yahoo Finance
Investing in Verona Pharma Plc ADR (VRNA) Is Getting More Attractive - Knox Daily
Li Auto Inc. Sponsored ADR (LI) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Verona Pharma's SWOT analysis: stock soars on Ohtuvayre approval, COPD market potential - Investing.com India
Market Momentum Report: Verona Pharma Plc ADR (VRNA)’s Positive Close at 28.76 - The Dwinnex
Verona Pharma's SWOT analysis: stock soars on Ohtuvayre approval, COPD market potential By Investing.com - Investing.com South Africa
Why Sea Limited Sponsored ADR (SE) Dipped More Than Broader Market Today - Yahoo Finance
Verona Pharma Plc ADR [NASDAQ: VRNA] Sees Decrease in Stock Value - Knox Daily
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
Sea Limited Sponsored ADR (SE) Outperforms Broader Market: What You Need to Know - Yahoo Finance
The growth track for Verona Pharma Plc ADR (VRNA) has changed recently - SETE News
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - Yahoo Finance
Are You Looking for a Top Momentum Pick? Why Taylor Wimpey PLC Unsponsored ADR (TWODY) is a Great Choice - Yahoo Finance
Is America Movil, S.A.B. de C.V. Unsponsored ADR (AMX) Stock Undervalued Right Now? - Yahoo Finance
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
Investor’s Delight: Verona Pharma Plc ADR (VRNA) Closes Weak at 29.60, Down -1.30 - The Dwinnex
Does Verona Pharma Plc ADR (NASDAQ: VRNA) Still Look Hot This Week? - Stocks Register
Verona Pharma Plc ADR (VRNA) deserves closer scrutiny - US Post News
NAM Ranked the #1 ADR Provider by the New York Law Journal for the 14th Consecutive Year - Yahoo Finance
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):